


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.69%
-0.40%
+6.54%
-0.38%
+15.99%
WVE
Wave Life Sciences
$12.46
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market
WVE Price Performance
$13.09 (-4.81%)
$15.54 (-19.82%)
$7.85 (+58.73%)
$7.74 (+60.98%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Outperform the market
WVE Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
WVE Street Sentiment is bullish and have negative views on the near-term outlook
WVE has Low risk level
Risk Indicators
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Dec 31, 2025
Upgrade
Buy
H.C. Wainwright
Dec 17, 2025
Reiterate
Outperform
Oppenheimer
Dec 13, 2025
Reiterate
Buy
B. Riley
Dec 12, 2025
Reiterate
Outperform
Wedbush
Dec 10, 2025
Reiterate
Buy
Canaccord Genuity
EBS
Emergent Biosolution
8.08
-3.00%
ARWR
Arrowhead Pharmaceuticals
57.57
+0.35%
SNY
Sanofi
44.06
+0.18%
NVS
Novartis AG
154.86
-0.01%
What is WVE current stock price?
What are WVE stock strengths?
What is WVE Risk Level?
What is WVE market cap and volume?
What is WVE current Stock IQ?
Should I buy WVE stock right now?
Is WVE a Strong Buy right now?
What does a 'Strong Buy' rating mean for WVE?
What does a 'Strong Sell' rating mean for WVE?
What factors influence WVE's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
WVE
Wave Life Sciences
Current Price
$12.46
Runners Also Watch
EBS
Emergent Biosolution
8.08
-3.00%
ARWR
Arrowhead Pharmaceuticals
57.57
+0.35%
SNY
Sanofi
44.06
+0.18%
NVS
Novartis AG
154.86
-0.01%

WVE Price Performance
$13.09 (-4.81%)
$15.54 (-19.82%)
$7.85 (+58.73%)
$7.74 (+60.98%)
WVE Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Outperform the market
WVE Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
WVE Street Sentiment is bullish and have negative views on the near-term outlook
WVE has Low risk level
Risk Indicators
Average key support and resistance price levels
Overall Wall Street Rating
WVE Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market
WVE Trading Signals
WVE showing early bearish trend, price below MA20 (13.38) and MA20 below MA50 (14.18)
WVE is trading 23.27% below analyst target price of $15.36, suggesting significant upside potential
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.